Skip to main content

Research Repository

Advanced Search

All Outputs (2)

Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British Society for Haemostasis and Thrombosis annual meeting. (2023)
Journal Article
WHYTE, C.S., MORROW, G.B., GAUER, J.S., MONTAGUE, S.J. and NICOLSON, P.L.R. 2023. Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British Society for Haemostasis and Thrombosis annual meeting (BSHT2023), 25-27 January 2023, Birmingham, UK. Front in cardiovascular medicine [online], 10, article number 1225243. Available from: https://doi.org/10.3389/fcvm.2023.1225243

The BSHT held its annual meeting between January 25th and 27th 2023 at the Edgbaston Park Hotel & Conference Centre, Birmingham, United Kingdom. The meeting is an opportunity for academic researchers, biomedical scientists and clinicians to network a... Read More about Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British Society for Haemostasis and Thrombosis annual meeting..

Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability. (2023)
Journal Article
MITCHELL, J.L., LITTLE, G., BYE, A.P. et al. 2023. Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability. Research and practice in thrombosis and haemostasis [online], 7(5), article 100200. Available from: https://doi.org/10.1016/j.rpth.2023.100200

Factor XIII (FXIII) is an important proenzyme in the hemostatic system. The plasma-derived enzyme activated FXIII cross-links fibrin fibers within thrombi to increase their mechanical strength and cross-links fibrin to fibrinolytic inhibitors, specif... Read More about Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability..